Bausch Health Companies Inc.
https://www.bauschhealth.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bausch Health Companies Inc.
Bausch + Lomb Patiently 'Semi-Private' While Bausch Health Plots Path To Spin-Out Completion
B+L using period of Bausch Health’s near-full ownership to plan for future. "When the spin comes, then we can spend a lot more time with our investors. But right now, I just have to take the elevator down two floors and I can see the 90% shareholder,” says CEO Brent Saunders.
Terns Hits In NASH, But Trails Its Rivals
TERN-501 monotherapy looks serviceable in a mid-stage NASH trial, but others are ahead. Perhaps partnership is the way forward.
Finance Watch: Apogee, Sagimet Launch First Big US IPOs Of The Summer
Public Company Edition: Apogee grossed $300m and Sagimet raised $85m in the biggest initial public offerings in the US since Acelyrin’s $540m IPO in May. Also, Bausch entered into a $600m funding facility with KKR, Bicycle raised $200m in a FOPO and Caribou garnered $150m from an offering and Pfizer.
Intercept Ends NASH Development, But Other Firms’ FXR Agonist Programs Ongoing
While Intercept is calling it quits in NASH with its FXR agonist obeticholic acid following a second complete response letter, other companies are staying the course with Phase II molecules in the class.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- AB Sanitas
- Afexa Life Sciences Inc.
- Amoun Pharmaceutical
- Aton Pharma, Inc.
- Bausch Health Ireland Limited
- Bausch + Lomb Holding International
- Biovail Corporation
- Callisto Pharmaceuticals, Inc. Dendreon Corporation
- Dermik Laboratories, Inc.
- Dow Pharmaceutical Sciences, Inc.
- Eyetech Inc.
- Graceway Pharmaceuticals, LLC
- ICN Pharmaceuticals, Inc.
- iNova Diagnostics, Inc.
- Instituto Terapeutico Delta Ltda
- Medicis Aesthetics Holdings Inc
- Medicis Pharmaceutical Corporation
- Mercury (Cayman) Holdings
- OraPharma, Inc.
- Ortho Dermatologics
- Prestwick Pharmaceuticals, Inc.
- PharmaSwiss S.A.
- Pedinol Pharmacal, Inc.
- Salix Pharmaceuticals Ltd. (InKine Pharmaceutical
- Oceana Therapeutics, LLC
- Q-Med Scandinavia, Inc.
- Santarus, Inc.)
- Sanitas AB
- Solta Medical, Inc.
- SPI Pharmaceuticals Inc
- Synergetics USA, Inc.
- Synergy Pharmaceuticals Inc.(SGYP)
- Technolas Perfect Vision GmbH (TPV)
- Ucyclyd Pharma, Inc.
- Unilens Vision, Inc.
- Viratek Pharma Inc
- Valeant Pharmaceuticals International, Inc.
- Xcel Pharmaceuticals, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice